跳至主要内容
临床试验/ITMCTR2100005320
ITMCTR2100005320尚未招募4 期

Clinical effect of Naoxue oral liquid on patients with spontaneous cerebral hemorrhage: a single-center, open, non-randomized controlled study

orth China University of Science and Technology Affiliated Hospital0 个研究点开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
18 至 80(—)
性别
All

入选标准

  • inclusion criteria:
  • 1. Patients who were confirmed by magnetic resonance imaging ((MRI)) and computerized tomography ((CT)) and met the criteria for the diagnosis and treatment of SICH approved in the AHA/ASA guidelines were selected.
  • 2.the amount of supratentorial bleeding = 30ml, the displacement of midline does not exceed 5mm, and the amount of subependental bleeding = 10ml.
  • 3. The age is between 18 and 80 years old.
  • 4. Select SICH patients within one week of onset
  • 5. The NIHSS score is between 2 and 20.
  • 6. Obtain the informed consent of the patient.

排除标准

  • 1.the amount of supratentorial bleeding > 30ml, the shift of midline exceeded 5mm, and the amount of subependental bleeding > 10ml.
  • 2. Severe dysarthria, hearing impairment, cognitive impairment and other reasons lead to the inability of patients to cooperate with the scale assessment.
  • 3. Patients with loss of consciousness and disturbance of consciousness
  • 4. Because of the insufficiency of important organs such as heart, liver and kidney, the researchers do not think it is suitable to participate in this study.
  • 5. A person with a serious mental illness.

研究者

发起方
orth China University of Science and Technology Affiliated Hospital

相似试验